One possible explanation for this outcome is that the study population included individuals with varying degrees of glucose intolerance, including both T2DM and pre-diabetes, which may have influenced the observed lipid profiles and attenuated the differences in AIP levels. The gene discussed is AIP; the disease is Glucose intolerance.